The CDC recommends that immunocompromised people and those age 65 and older should get a second dose of the 2024-2025 COVID ...

Clinical trials of single-agent targeted drugs have shown limited efficacy. In the only trial of single-agent immunotherapy ...

In the wake of the elimination diets, 38% of the parents reported no improvement in their child’s AD, 35% reported a 25% ...

Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the ...

These two stocks have moved in different directions this year, but that shouldn't mean much to long-term investors.

A key panel of U.S. health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and ...

Buying high-yielding dividend stocks can be scary, even when it's not Halloween. You can be tricked into thinking that a high ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

As more Big Pharma companies have launched direct-to-consumer telehealth platforms, lawmakers have raised concerns they might ...

Housed in a 53′, state-of-the-art, double expandable trailer on wheels, Pfizer School of Science Mobile Experience will travel to select parts of the country throughout 2024 and 2025 to bring the ...

The 2024-2025 COVID-19 vaccines are available, and the CDC recommends that certain groups get two doses, spaced six months ...

The statement read: “NAFDAC enforcement officers, aided by intelligence from the Nigerian Army’s 15 Field Engineering ...